Search / Trial NCT00001162

Parasitic Infections of the Gastrointestinal Tract

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Nov 3, 1999

Trial Information

Current as of October 18, 2024

Terminated

Keywords

Giardia Helminth Cryptosporidium Hookworms Trichuris Strongyloides Protozoa Small Bowel Biopsy E. Histolytica Duodenal Aspiration Coccidiosis Clonorchis Amebiasis Parasitic Disease Tapeworm Trichinosis Gastrointestinal Trematodes Opisthorchis Paragonimiasis Echinococcus

Description

The precis of this protocol is to allow the evaluation, treatment and study of patients with a variety of gastrointestinal parasites. This protocol primarily allows evaluation and treatment of patients with any intestinal parasite that requires a medical evaluation. The treatment and evaluation consists of standard of care. Research aspects include the collection and study of different parasite populations, analysis of the immune responses of the host, a correlation between parasite burden in the host and disease. These patients also serve as a source of reagents such as feces, white blood ...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Persons with proven or highly suspected parasitic infections involving the gastrointestinal tract (including amebiasis, giardiasis, hookworm, strongyloidiasis, trichuriasis, pinworm, tapeworm, cyclorsporiasis, cryptosporidia infections, microsporidia infections, isosporidium infections, trichinosis, gastrointestinal dwelling trematodes, coccdioiosis, and echinococccus and additional infections).
  • Persons older than 2.
  • Ability and willingness of the subject or legal guardian/representative to give written informed consent.
  • EXCLUSION CRITERIA:
  • Subject unwilling or unable to comply with requirements of the protocol in the opinion of the investigator.

About National Institute Of Allergy And Infectious Diseases (Niaid)

The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0